Ascorbic acid: a useful reductant to avoid oxidation of catecholamines in electrophysiological experiments in vitro?
The actions of the reductant ascorbic acid on rat neocortical neurons in vitro was investigated by means of intracellular recordings. At a concentration (500 microM), which reduced the magnitude of dopamine degradation in oxygen-saturated saline solutions by about 50%, ascorbic acid reversibly depressed synaptic potentials and enhanced direct excitability of cortical neurons. The latter effect was not reversible within the observation period. Ascorbic acid did not alter membrane potential and input resistance of the neurons. On the basis of our results we conclude that ascorbic acid is not a useful reductant to avoid oxidation of catecholamines in oxygen-saturated solutions used in electrophysiological experiments in vitro.
Sutor
B
B
Physiologisches Institut, Universität München, F.R.G.
ten Bruggencate
G
G
D000818:Animals; D001205:Ascorbic Acid / Q000494:pharmacology*; D002395:Catecholamines / Q000378:metabolism*; D002540:Cerebral Cortex / Q000166:cytology / Q000187:drug effects; D002851:Chromatography, High Pressure Liquid; D004298:Dopamine / Q000378:metabolism; D004594:Electrophysiology / Q000379:methods*; D005625:Frontal Lobe / Q000378:metabolism; D009474:Neurons / Q000187:drug effects / Q000502:physiology; D010084:Oxidation-Reduction / Q000187:drug effects; D051381:Rats; D013569:Synapses / Q000502:physiology
D002395:Catecholamines; D001205:Ascorbic Acid; D004298:Dopamine